Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Florida International University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Florida International University
Duke University
University of South Florida
National Cancer Institute (NCI)
University of Minnesota
Children's Oncology Group
University of South Florida
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Pediatric Brain Tumor Consortium
Pediatric Brain Tumor Consortium